Companies:
53,126
Total Market Cap:
168041219902186.44
Enlivex Therapeutics Ltd.
NASDAQ: ENLV
Healthcare
Biotechnology
Global Rank
#27691
Country Rank
#366
Market Cap
75.21 M
Price
4.68
Change (%)
1.47%
Volume
118,202
Enlivex Therapeutics Ltd.'s latest marketcap:
75.21 M
As of 07/19/2026, Enlivex Therapeutics Ltd.'s market capitalization has reached $75.21 M. According to our data, Enlivex Therapeutics Ltd. is the 27691th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 75.21 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 1.24 B |
| Shares Out | 16.07 M |
| EPS (ttm) | 382.2 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/28/2026 |
Market Cap Chart
Data Updated: 07/19/2026
Enlivex Therapeutics Ltd.'s yearly market capitalization.
Enlivex Therapeutics Ltd. has seen its market value drop from $83.1 M to $75.21 M since 2014, representing a total decrease of 9.50% and an annual compound decline rate (CAGR) of 0.86%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/19/2026 | $75.21 M | -4.68% | 27691 |
| 12/31/2025 | $166.93 M | 548.82% | 34143 |
| 12/31/2024 | $25.73 M | -48.77% | 32515 |
| 12/29/2023 | $50.22 M | -30.73% | 27729 |
| 12/30/2022 | $72.5 M | -36.72% | 24362 |
| 12/31/2021 | $114.57 M | 31.53% | 22242 |
| 12/31/2020 | $87.1 M | 2388.57% | 21405 |
| 12/31/2019 | $3.5 M | 34.62% | 31449 |
| 12/31/2018 | $2.6 M | -65.33% | 30957 |
| 12/29/2017 | $7.5 M | -49.32% | 28302 |
Company Profile
Enlivex Therapeutics Ltd. was founded in 2005 in Israel.
The company went public on 12/12/1995
on the Nasdaq Stock Market.
With 34 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Enlivex Therapeutics Ltd.'s (ENLV) current market cap?As of 07/19/2026, Enlivex Therapeutics Ltd. (including the parent company, if applicable) has an estimated market capitalization of $75.21 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Enlivex Therapeutics Ltd. (ENLV) rank globally by market cap?Enlivex Therapeutics Ltd. global market capitalization ranking is approximately 27691 as of 07/19/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.